chr11-94434611-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005591.4(MRE11):​c.1994+1221C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.399 in 151,674 control chromosomes in the GnomAD database, including 12,325 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12325 hom., cov: 31)

Consequence

MRE11
NM_005591.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.124

Publications

10 publications found
Variant links:
Genes affected
MRE11 (HGNC:7230): (MRE11 homolog, double strand break repair nuclease) This gene encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. By itself, the protein has 3' to 5' exonuclease activity and endonuclease activity. The protein forms a complex with the RAD50 homolog; this complex is required for nonhomologous joining of DNA ends and possesses increased single-stranded DNA endonuclease and 3' to 5' exonuclease activities. In conjunction with a DNA ligase, this protein promotes the joining of noncomplementary ends in vitro using short homologies near the ends of the DNA fragments. This gene has a pseudogene on chromosome 3. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MRE11 Gene-Disease associations (from GenCC):
  • ataxia-telangiectasia-like disorder 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • prostate cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005591.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
NM_005591.4
MANE Select
c.1994+1221C>T
intron
N/ANP_005582.1P49959-1
MRE11
NM_001440460.1
c.1994+1221C>T
intron
N/ANP_001427389.1
MRE11
NM_001440461.1
c.1994+1221C>T
intron
N/ANP_001427390.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MRE11
ENST00000323929.8
TSL:1 MANE Select
c.1994+1221C>T
intron
N/AENSP00000325863.4P49959-1
MRE11
ENST00000323977.7
TSL:1
c.1910+1221C>T
intron
N/AENSP00000326094.3P49959-2
MRE11
ENST00000936196.1
c.1994+1221C>T
intron
N/AENSP00000606255.1

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
60410
AN:
151556
Hom.:
12313
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.464
Gnomad AMI
AF:
0.0912
Gnomad AMR
AF:
0.397
Gnomad ASJ
AF:
0.370
Gnomad EAS
AF:
0.420
Gnomad SAS
AF:
0.472
Gnomad FIN
AF:
0.360
Gnomad MID
AF:
0.484
Gnomad NFE
AF:
0.363
Gnomad OTH
AF:
0.421
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.399
AC:
60459
AN:
151674
Hom.:
12325
Cov.:
31
AF XY:
0.401
AC XY:
29714
AN XY:
74076
show subpopulations
African (AFR)
AF:
0.464
AC:
19196
AN:
41352
American (AMR)
AF:
0.397
AC:
6038
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
1285
AN:
3470
East Asian (EAS)
AF:
0.419
AC:
2146
AN:
5126
South Asian (SAS)
AF:
0.474
AC:
2270
AN:
4794
European-Finnish (FIN)
AF:
0.360
AC:
3773
AN:
10484
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.363
AC:
24646
AN:
67916
Other (OTH)
AF:
0.417
AC:
878
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1788
3575
5363
7150
8938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.379
Hom.:
1895
Bravo
AF:
0.402
Asia WGS
AF:
0.445
AC:
1548
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.9
DANN
Benign
0.57
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs601341; hg19: chr11-94167777; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.